Episode 3: Factor XIa Inhibitors: A Breakthrough in Anticoagulation? - Heart Failure Treatment: New Concepts for 2023 and Beyond

ESC TV Today – Your Cardiovascular News

Oct 27 2022 • 22 mins

ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.

This episode tackles:

  • Cardiology this Week
  • Factor XIa Inhibitors: A Breakthrough in Anticoagulation?
  • Heart Failure Treatment: New Concepts for 2023 and Beyond
  • Snapshots

Host: Susanna Price
Guests: Carlos Aguiar, Robert Storey, Carolyn Lam and Stephan Achenbach

Want to watch that episode? Go to: https://esc365.escardio.org/event/602


Disclaimer:
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.

Declarations of interests

Stephan Achenbach, Nicolle Kraenkel, Susanna Price and Robert Storey declared to have no potential conflict of interest to report.
Carlos Aguiar declared to have potential conflict of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno declared to have potential conflict of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Carolyn Lam declared to have potential conflict of interest to report: Carolyn S.P. Lam is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Bayer and Roche Diagnostics; has served as consultant or on the Advisory Board/ Steering Committee/ Executive Committee for Actelion, Alleviant Medical, Allysta Pharma, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Eli Lilly, Impulse Dynamics, Intellia Therapeutics, Ionis Pharmaceutical, Janssen Research & Development LLC, Medscape/WebMD Global LLC, Merck, Novartis, Novo Nordisk, Prosciento Inc, Radcliffe Group Ltd., ReCor Medical, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics and Us2.ai; and serves as co-founder & non-executive director of Us2.ai.
Emma Svennberg declared to have potential conflict of interest to report: Institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme

You Might Like

The Mindset Mentor
The Mindset Mentor
Rob Dial and Kast Media
Huberman Lab
Huberman Lab
Scicomm Media
Relaxing White Noise
Relaxing White Noise
Relaxing White Noise, LLC
Become
Become
Amazon Music
Sleep With Me
Sleep With Me
Dearest Scooter
Sex With Emily
Sex With Emily
Dr. Emily Morse
UnF*ck Your Brain
UnF*ck Your Brain
Kara Loewentheil
Mind Pump: Raw Fitness Truth
Mind Pump: Raw Fitness Truth
Sal Di Stefano, Adam Schafer, Justin Andrews, Doug Egge
8 Hour Sleep Music
8 Hour Sleep Music
8-Hour Sleep Music
Maintenance Phase
Maintenance Phase
Aubrey Gordon & Michael Hobbes